Participation of the Entner-Doudoroff pathway in Escherichia coli strains with an inactive phosphotransferase system (PTS- Glc+) in gluconate and glucose batch cultures.

Can J Microbiol

Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE), Dept. Of Marine Biotechnology, Km 107 Carretera Tijuana-Ensenada, C.P. 22860 Ensenada, B.C., Mexico.

Published: November 2005

The activity of the enzymes of the central metabolic pathways has been the subject of intensive analysis; however, the Entner-Doudoroff (ED) pathway has only recently begun to attract attention. The metabolic response to edd gene knockout in Escherichia coli JM101 and PTS- Glc+ was investigated in gluconate and glucose batch cultures and compared with other pyruvate kinase and PTS mutants previously constructed. Even though the specific growth rates between the strain carrying the edd gene knockout and its parent JM101 and PTS- Glc+ edd and its parent PTS- Glc+ were very similar, reproducible changes in the specific consumption rates and biomass yields were obtained when grown on glucose. These results support the participation of the ED pathway not only on gluconate metabolism but on other metabolic and biochemical processes in E. coli. Despite that gluconate is a non-PTS carbohydrate, the PTS- Glc+ and derived strains showed important reductions in the specific growth and gluconate consumption rates. Moreover, the overall activity of the ED pathway on gluconate resulted in important increments in PTS- Glc+ and PTS- Glc+ pykF mutants. Additional results obtained with the pykA pykF mutant indicate the important contribution of the pyruvate kinase enzymes to pyruvate synthesis and energy production in both carbon sources.

Download full-text PDF

Source
http://dx.doi.org/10.1139/w05-101DOI Listing

Publication Analysis

Top Keywords

pts- glc+
28
entner-doudoroff pathway
8
escherichia coli
8
gluconate glucose
8
glucose batch
8
batch cultures
8
edd gene
8
gene knockout
8
jm101 pts-
8
pyruvate kinase
8

Similar Publications

Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source.

mSphere

December 2024

State Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, Fujian Province, China.

Article Synopsis
  • - The study reveals that Enzyme-IIA (EIIA) links glucose sugar uptake with a regulatory system affecting antibiotic resistance, where phosphorylated EIIA increases cAMP-Crp activity, leading to cell death through reactive oxygen species (ROS) accumulation.
  • - Mannitol, unlike other sugars that require EIIA for uptake, has been shown to reduce the effectiveness of antibiotics without changing their minimum inhibitory concentration, indicating it promotes antibiotic tolerance by inhibiting cAMP-Crp action.
  • - This research highlights that other non-glucose carbon sources like mannose and sorbitol can also induce similar antibiotic tolerance through a mechanism that lowers ROS activity, posing challenges for effective infection treatment.
View Article and Find Full Text PDF

Identification of a cellular role of hemolysin co-regulatory protein (Hcp) in Vibrio alginolyticus modulating substrate metabolism and biofilm formation by cAMP-CRP.

Int J Biol Macromol

December 2024

Guangdong Provincial Key Laboratory of Aquatic Animal Disease Control and Healthy Culture, College of Fishery, Guangdong Ocean University, Zhanjiang 524088, China; Key Laboratory of Diseases Controlling for Aquatic Economic Animals of Guangdong Higher Education Institutions, College of Fishery, Guangdong Ocean University, Zhanjiang 524088, China. Electronic address:

Cyclic AMP (cAMP) and cAMP receptor protein (CRP) system controls catabolic enzyme expression based on metabolite concentrations in bacteria. Hemolysin co-regulatory protein (Hcp) is well known as a molecular chaperone for virulence factor secretion of the type VI secretion system (T6SS). However, the intracellular role of Hcp involving in bacterial physiological processes remains unknown.

View Article and Find Full Text PDF

Engineering PTS-based glucose metabolism for efficient biosynthesis of bacterial cellulose by Komagataeibacter xylinus.

Carbohydr Polym

November 2024

State Key Laboratory of Food Nutrition &Safety, Tianjin University of Science and Technology, Tianjin 300457, PR China; Key Laboratory of Industrial Fermentation Microbiology (Ministry of Education), Tianjin University of Science and Technology, Tianjin 300457, PR China.

Bacterial cellulose (BC) is a renewable biomaterial that has attracted significant attention due to its excellent properties and wide applications. Komagataeibacter xylinus CGMCC 2955 is an important BC-producing strain. It primarily produces BC from glucose while simultaneously generating gluconic acid as a by-product, which acidifies the medium and inhibits BC synthesis.

View Article and Find Full Text PDF

Cyclic di-GMP Modulates a Metabolic Flux for Carbon Utilization in Salmonella enterica Serovar Typhimurium.

Microbiol Spectr

February 2023

Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.

Salmonella enterica serovar Typhimurium is an enteric pathogen spreading via the fecal-oral route. Transmission across humans, animals, and environmental reservoirs has forced this pathogen to rapidly respond to changing environments and adapt to new environmental conditions. Cyclic di-GMP (c-di-GMP) is a second messenger that controls the transition between planktonic and sessile lifestyles, in response to environmental cues.

View Article and Find Full Text PDF

Module-Guided Metabolic Rewiring for Fucosyllactose Biosynthesis in Engineered with Lactose Pathway.

J Agric Food Chem

November 2022

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China.

Fucosyllactose (FL) has garnered considerable attention for its benefits on infant health. In this study, we report an efficient cell factory to produce 2'/3-fucosyllactose (2'/3-FL) with lactose pathway through metabolic network remodeling, including (1) modification of the PTS system to enhance glucose internalization efficiency; (2) screening for β-1,4-galactosyltransferase (β-1,4-GalT) and introduction of lactose synthesis pathway; (3) eliminating inhibition of byproduct pathways; (4) constructing antibiotic-free and inducer-free FL strains; and (5) up-regulating the expression of genes in the GDP-l-fucose module. The final engineered strains BP10-3 and BP11-3 produced 4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!